AbbVie ABBV Finite-Lived Intangible Assets, Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbbVie's finite-lived intangible assets, accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbbVie's finite-lived intangible assets, accumulated amortization?
- AbbVie (ABBV) reported finite-lived intangible assets, accumulated amortization of $43.92B in Q1 2026.
- How has AbbVie's finite-lived intangible assets, accumulated amortization changed year-over-year?
- AbbVie's finite-lived intangible assets, accumulated amortization increased by 19.4% year-over-year, from $36.79B to $43.92B.
- What is the long-term trend for AbbVie's finite-lived intangible assets, accumulated amortization?
- Over 5 years (2020 to 2025), AbbVie's finite-lived intangible assets, accumulated amortization has grown at a 23.8% compound annual growth rate (CAGR), from $14.54B to $42.23B.